null
ChEBI ID: 47814
| Member | Definition | Role |
|---|---|---|
| empagliflozin | A C-glycosyl compound consisting of a beta-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. | empagliflozin |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 593 (42.51) | 24.3611 |
| 2020's | 802 (57.49) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 313 (21.90%) | 5.53% |
| Reviews | 257 (17.98%) | 6.00% |
| Case Studies | 50 (3.50%) | 4.05% |
| Observational | 29 (2.03%) | 0.25% |
| Other | 780 (54.58%) | 84.16% |